Migraine Modulation and Debut after Percutaneous Atrial Septal Defect Closure: A Review. - Wikidata - wikimedia - TriplyDB

Migraine Modulation and Debut after Percutaneous Atrial Septal Defect Closure: A Review.

Migraine Modulation and Debut after Percutaneous Atrial Septal Defect Closure: A Review.

http://www.wikidata.org/entity/Q37710416

about

Migraine Modulation and Debut after Percutaneous Atrial Septal Defect Closure: A Review.

http://www.wikidata.org/entity/Q37710416

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 20 March 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Migraine Modulation and Debut after Percutaneous Atrial Septal Defect Closure: A Review.

@en

Migraine Modulation and Debut after Percutaneous Atrial Septal Defect Closure: A Review.

@nl

type

label

Migraine Modulation and Debut after Percutaneous Atrial Septal Defect Closure: A Review.

@en

Migraine Modulation and Debut after Percutaneous Atrial Septal Defect Closure: A Review.

@nl

prefLabel

Migraine Modulation and Debut after Percutaneous Atrial Septal Defect Closure: A Review.

@en

Migraine Modulation and Debut after Percutaneous Atrial Septal Defect Closure: A Review.

@nl

P1433

Q37710416-975B0172-6D08-46EF-82F0-005FC4FEF3C9

P1476

Q37710416-54DC2F3F-8086-4EE3-B708-26EEE4066DE3

P2093

Q37710416-7B81B4FC-3EF9-450B-9D4A-5331F88C2B8D

Q37710416-FD446DCF-71A1-4BA8-98E3-0DFFD913ED9A

P2860

Q37710416-0310FB5F-BCA7-48F9-9A71-27E46BD8DC26

Q37710416-056FFD26-1B45-4404-B45D-160B99345FAF

Q37710416-061E8623-67E8-47F1-A9E8-1A179B0CBB7B

Q37710416-0CBA172A-D4ED-4FE1-BF94-4D09857A815C

Q37710416-0D7AB4B1-2528-4062-8685-9D6830E44A8C

Q37710416-0E06BF2A-8EC0-4351-BF33-A185831026FE

Q37710416-1121F88C-966D-41CE-BC81-889A410F0FA6

Q37710416-126E4395-F62D-4428-AC04-366544070657

Q37710416-141B652E-D398-4502-AFBA-3E5398E65F48

Q37710416-14FA7560-B3FC-49A3-B5BF-F1F272ED6412

P304

Q37710416-BBD9C55F-ECA4-461E-BC41-A926B853848F

P31

Q37710416-9FC7E22A-E18F-4431-81EB-352DF7F7AE4B

P356

Q37710416-7C9BBCFA-316B-4057-8E3C-679FE3D5035C

P478

Q37710416-47123689-2523-47B8-8B08-E8CA4A3302FE

P577

Q37710416-3379BA15-C45D-4C2C-90AF-AC8355170762

P698

Q37710416-B1AE4091-365F-4C90-A50C-FF0F937ED4D6

P921

Q37710416-5B920849-2900-4772-A5A0-AFD4171BD059

P932

Q37710416-E082A16D-C1AB-4316-8625-F006A277D9E8

P356

FNEUR.2017.00068

P1433

Frontiers in Neurology

P1476

Migraine Modulation and Debut after Percutaneous Atrial Septal Defect Closure: A Review.

@en

P2093

Charles Stevens Leger

http://www.w3.org/2001/XMLSchema#string

Joseph F X DeSouza

http://www.w3.org/2001/XMLSchema#string

P2860

Mechanisms of migraine aura revealed by functional MRI in human visual cortex

Migraine and cardiovascular disease: systematic review and meta-analysis

Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects

Sex differences in platelet reactivity and response to low-dose aspirin therapy

Cerebral microembolism is blocked by tirofiban, a selective nonpeptide platelet glycoprotein IIb/IIIa receptor antagonist

Neuronal signal substances as biomarkers of migraine

Vasoactive peptide release in the extracerebral circulation of humans during migraine headache

Calcitonin gene-related peptide and its role in migraine pathophysiology

Clinical and preclinical rationale for CGRP-receptor antagonists in the treatment of migraine

The International Classification of Headache Disorders, 3rd edition (beta version)

P304

68

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FNEUR.2017.00068

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28373854

http://www.w3.org/2001/XMLSchema#string

P921

migraine disorder

P932

5357661

http://www.w3.org/2001/XMLSchema#string